GLP-1 Medicaid Coverage by State (2026)

Published 2026-07-01 · Updated 2026-07-08 · MetaDose Research

Free comparison

Compare GLP-1 providers & cash-pay options

See telehealth and pharmacy programs that may lower your monthly cost.

MetaDose may earn a fee through partner links. See our disclaimer.

Medicaid is not one national formulary. Each state (and often each managed-care plan inside the state) publishes a preferred drug list (PDL) with different rules for Ozempic, Wegovy, Mounjaro, and Zepbound. In 2026, diabetes indications are covered more often than obesity brands. Copays, when covered, are usually tiny — the hard part is coverage itself.

Indication split that drives almost every decision

Never assume last year’s coverage. States add, carve out, or prefer agents mid-year when budgets tighten.

  • Type 2 diabetes: Ozempic / Mounjaro more likely on PDL with PA
  • Obesity / weight management: Wegovy / Zepbound still limited on many Medicaid programs
  • Medicare is a different channel — use Medicare GLP-1 guide for Part D questions

Copays when covered — and gaps when not

Covered Medicaid GLP-1 fills often land at $0–$3. When not covered, manufacturer copay cards usually cannot be used (government exclusion). Fall back to assistance programs or cash/compounded paths via cheapest GLP-1 without insurance.

How to check your state without guessing

GLP-1 cost by state

Frequently Asked Questions

Does Medicaid cover Wegovy?

Only in some states/programs in 2026 — verify the current PDL for your plan, not national headlines.

Can I use a savings card with Medicaid?

Almost never. Manufacturer cards exclude government programs.

Related tools & pages

More GLP-1 guides

View all 39 guides →